Synthesis and antioxidant capacities of some new benzimidazole derivatives

Archiv der Pharmazie

Volumn 340, Issue 11, 2007, Pages 607-611

  Ayhan Kilcigil, Gülgün ^a   Kuş, Canan ^a   Özdamar, Elçin D ^a   Can Eke, Benay ^a   Içan, Mümtaz ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Antioxidant activity; Benzimidazoles; Oxadiazoles

Indexed keywords

1 (4 CHLOROBENZYL) 2 PHENYL 1H BENZIMIDAZOLE 5 ACETIC ACID HYDRAZIDE; 5 (2 PHENYLBENZIMIDAZOLE 1 YLMETHYL) 2 MERCAPTO[1,3,4]OXADIAZOLE; 5 [1 (4 CHLOROBENZYL) 2 PHENYLBENZIMIDAZOL 1 YLMETHYL] 2 MERCAPTO[1,3,4]OXADIAZOLE; 5 [2 (4 CHLOROPHENYL)BENZIMIDAZOL 1 YLMETHYL] 2 MERCAPTO[1,3,4]OXADIAZOLE; 5 [2 (4 METHOXYPHENYL) BENZIMIDAZOL 1 YLMETHYL] 2 MERCAPTO[1,3,4]OXADIAZOLE; 5 [2 (4 PYRIDINYLBENZIMIDAZOL 1 YLMETHYL] 2 MERCAPTO[1,3,4]OXADIAZOLE; 5 [5,6 DICHLORO 2 (3,4 DIMETHOXY)PHENYLBENZIMIDAZOL 1 YLMETHYL] 2 MERCAPTO[1,3,4]OXADIAZOLE; 5,6 DICHLORO 2 (3,4 DIMETHOXYPHENYL) 1H BENZIMIDAZOLE ACETIC ACID HYDRAZIDE; 5,6 DICHLORO 2 [(3,4 DIMETHOXY)PHENYL] 1H BENZIMIDAZOLE; ANTIOXIDANT; BENZIMIDAZOLE DERIVATIVE; CAFFEINE; ETHOXYRESORUFIN DEETHYLASE; ETHYL 5,6 DICHLORO 2 (3,4 DIMETHOXYPHENYL) 1H BENZIMIDAZOLE ACETATE; LIPID; METHYL 1 (4 CHLOROBENZYL) 2 PHENYL 1H BENZIMIDAZOLE 5 ACETATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME ACTIVITY; IC 50; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; BENZIMIDAZOLES; CYTOCHROME P-450 CYP1A1; DRUG DESIGN; LIPID PEROXIDATION; MALE; MICROSOMES, LIVER; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 36549058379     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200700088     Document Type: Article

References (15)

1. C. Kuş, G. Ayhan-Kilcigil, B. Can Eke, M. Işcan, Arch. Pharm. Res. 2004, 27, 156-163.
2. G. Ayhan-Kilcigil, C. Kuş, T. Çoban, B. Can-Eke, M. Işcan, J. Enzyme Inhib. Med. Chem. 2004, 19, 129-135.
3. Z. Ateş-Alagöz, C. Kuş, T. Çoban, J. Enzyme Inhib. Med. Chem. 2005, 20, 325-333.
4. G. Ayhan-Kilcigil, C. Kuş, T. Çoban, B. Can-Eke, et al., J. Enzyme Inhib. Med. Chem. 2005, 20, 503-514.
5. I. Kerimov, G. Ayhan-Kilcigil, B. Can-Eke, N. Altanlar, M. Işcan, J. Enzyme Inhib. Med. Chem. 2007 (in press).
6. H. F. Ridley, R. G. W. Spickett, G. M. Timmis, J. Heterocycl. Chem. 1965, 2, 453-456.
7. H. Heaney, S. V. Ley, J. Chem. Soc. Perkin 1, 1973, 499-500.
8. P. A. S. Smith in Organic Reactions, Volume III, (Eds.: R. Adams, W. E. Bachmann, L. F. Fieser, J. R. Johnson, H. R. Snyder) John Wiley & Sons, Inc. London, Chapman & Hall, Ltd, 1949, pp. 337-389.
9. N. Demirbaş, Turk. J. Chem. 2005, 29, 125-133.
10. H. Göker, E. Tebrizli, U. Abbasoglu, Farmaco 1996, 51, 53-58.
11. M. Işcan, E. Arinç, N. Vural, M. Y. Işcan, Comp. Biochem. Physiol. 1984, 77C, 177-190.
12. E. D. Wills, Biochem. J. 1966, 99, 667-676.
13. E. D. Wills, Biochem. J. 1969, 113, 333-341.
14. S. Bishayee, A. S. Balasubramanian, Neurochem. 1971, 18, 909-920.
15. M. D. Burke, S. Thompson, C. R. Elcombe, J. Halpert, et al., Biochem. Pharmacol. 1985, 34, 3337-3345.